Live tape
Top 8, mentions 7d28,006NVDA16,801 mentions▲ +0.03MSFT1,909 mentions-0.02AMD1,890 mentions▲ +0.10GOOGL1,869 mentions▲ +0.04AAPL1,527 mentions▲ +0.05SPCX1,463 mentions▲ +0.07SPY1,351 mentions▲ +0.05NBIS1,196 mentions▲ +0.07

Equity · Healthcare

NNVC

AMEX

NanoViricides (NNVC)

1.76 USD −0.85% vs prior close
NanoViricides, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
44.8M USD
Revenue, year to Jun 2026
0 USD
EPS, diluted, year to Jun 2026
−0.41 USD
52-week range
0.8525 USD – 2.02 USD
Avg volume
33.6K

as of Jul 17, 2026

Which funds hold NanoViricides (NNVC)?

1 of the 45 institutional funds we track reported a NanoViricides position for the quarter ended 30 Sep 2026 — a combined 128K USD; the latest of those filings landed 12 Nov 2026.

Form 13F

Which funds hold NanoViricides (NNVC)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)98,300128K USD−23.6%

What has been filed or recorded for NanoViricides (NNVC)?

The filings we hold for NanoViricides, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Jun 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for NanoViricides (NNVC)?
And
30 Jun 2026Annual reportFY 2026 reportedEPS −0.41 USD
30 Jun 2026FinancialsRevenue0 USDfiscal year
30 Jun 2026FinancialsNet income−8.2M USDfiscal year
30 Jun 2026FinancialsDiluted EPS−0.41 USDfiscal year
30 Jun 2026FinancialsTotal assets9.9M USDat period end
30 Jun 2026FinancialsTotal equity8.7M USDat period end
31 Mar 2026Quarterly earningsQ3 2026 reportedEPS −0.09 USD
31 Dec 2025Quarterly earningsQ2 2026 reportedEPS −0.11 USD
30 Sep 2025Quarterly earningsQ1 2026 reportedEPS −0.10 USD
30 Jun 2025Annual reportFY 2025 reportedEPS −0.63 USD
31 Mar 2025Quarterly earningsQ3 2025 reportedEPS −0.14 USD
31 Dec 2024Quarterly earningsQ2 2025 reportedEPS −0.14 USD
30 Sep 2024Quarterly earningsQ1 2025 reportedEPS −0.23 USD

What do people ask about NanoViricides (NNVC)?

From live data
What is NanoViricides’ market cap?44.8M

NanoViricides is worth 44.8M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is NanoViricides’ revenue?0

NanoViricides reported revenue of 0 USD for the year ended 30 Jun 2026, as filed with the SEC. See Filings

Which funds own NanoViricides?1 of 45

1 of the 45 funds we track reported a NanoViricides position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Renaissance Technologies. See Funds

When did NanoViricides last report earnings?−0.41

NanoViricides last reported earnings on 30 Jun 2026 for FY 2026, with EPS of −0.41 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGAR13F filings
  4. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  5. SEC EDGARreported earnings figures and scheduled report dates
  6. SEC EDGARValuation computed from SEC EDGAR filings